A1CF and renal carcinoma: Collectively, the results of the xenografted mouse model and clinical sample analysis indicated that A1CF possessed oncogenic promotion characteristics and that A1CF–NKRF interaction resulted in the reduction in phosphorylated-p65(S536) and IFNβ nuclear protein levels, which may be the cause of renal carcinoma genesis.